Skip to main content

Thermo Fisher Completes Lomb Acquisition

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it has completed the acquisition of Lomb Scientific, a provider of lab chemicals, consumables, and instruments in Australia and New Zealand, for an undisclosed sum.

Lomb Scientific, which will be integrated into Thermo Fisher's Laboratory Products and Services and Analytical Technologies segments, had revenues in 2009 of A$34 million ($32.8 million), and it has around 100 employees.

The deal was initially announced at the beginning of December.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.